GENETIC-VIRAL-IMMUNOLOGIC STUDIES IN NEW ZEALAND MICE
新西兰小鼠的遗传病毒免疫学研究
基本信息
- 批准号:3169908
- 负责人:
- 金额:$ 29.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-07-01 至 1992-04-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte Retroviridae disease T lymphocyte antiantibody antibody formation antibody specificity antigen antibody reaction antiidiotype antibody autoantibody autoimmune disorder biological models cellular oncology electrofocusing endonuclease gene expression genetic mapping genetic regulation glomerulonephritis hybridomas immunogenetics immunoprecipitation immunoregulation laboratory mouse lymphoma murine leukemia virus neoplasm /cancer genetics oncogenes scintillation counter tissue /cell culture virus genetics virus morphology virus protein
项目摘要
The major goal of this research project is to determine the fundamental
mechanisms of autoimmune disease and malignant lymphomas that develop
spontaneously in autoimmune NZB mice and their crosses with the normal SWR
mice. The NZB x SWR crosses have not only proved useful to dissect the
role of various abnormalities of the NZB strain in the etiology of
autoimmune disease, but are also helping us to identify the factors
contributed by a normal strain in the development of lupus nephritis.
AImost 100% of (NZB x SWR) F1 mice rapidly develop a lethally severe
glomerulonephritis, in marked contrast to their autoimmune NZB parents.
Monoclonal anti-DNA autoantibodies derived from the F1 mice by hybridoma
technology will be analyzed for their antigen-binding specificity patterns,
spectrotypes and allotypes. The F1-derived autoantibodies that are encoded
by genes inherited from the NZB parent and those that are encoded by
antibody genes from the SWR parent will be identified. Anti-idiotypic
antibodies specific for these autoantibodies will be raised. These
reagents will be used to study the inheritance and regulation of expression
of these autoantibody idiotypes and their relation to nephritis development
in NZB x SWR crosses. These autoantibody idiotypes will be deliberately
suppressed to prevent the development of nephritis. The major genes
determining the development of autoimmune disease will be identified and
mapped by constucting recombinant inbred and congenic lines of mice.
Finally, to define the mechanism of lymphoid malignancy, the cellular
origin of the NZB lymphomas will be determined. The genomic structure of
viruses produced by the lymphomas will be analyzed by T1 oligonucleotide
fingerprinting and restriction endonuclease mapping techniques.
Rearrangement of retroviral genes and cellular oncogenes in the lymphomas
will also be studied. (MI)
本研究项目的主要目标是确定
自身免疫性疾病和恶性淋巴瘤的发病机制
在自身免疫NZB小鼠及其与正常SWR的杂交中自发地
小鼠 NZB x SWR杂交不仅被证明有助于解剖
NZB菌株的各种异常在
自身免疫性疾病,但也帮助我们确定的因素,
狼疮性肾炎是由正常的狼疮性肾炎引起的。
几乎100%的(NZB x SWR)F1小鼠迅速发展为致死性重度
肾小球肾炎,与自身免疫性NZB父母形成鲜明对比。
用杂交瘤技术制备抗DNA单克隆抗体
技术将分析其抗原结合特异性模式,
spectrotypes和allotypes。 编码的F1衍生自身抗体
由遗传自NZB亲本的基因和那些由
将鉴定来自SWR亲本的抗体基因。 抗独特
将产生对这些自身抗体特异的抗体。 这些
试剂将用于研究遗传和表达调控
这些自身抗体独特型及其与肾炎发展的关系
在NZB x SWR的十字架。这些自身抗体独特型将被故意
抑制以防止肾炎的发展。 主基因
确定自身免疫性疾病的发展将被确定,
通过构建小鼠的重组近交系和同源系来作图。
最后,为了明确淋巴恶性肿瘤的机制,细胞免疫学检查显示,
将确定NZB淋巴瘤的起源。的基因组结构
将通过T1寡核苷酸分析淋巴瘤产生的病毒
指纹图谱和限制性内切酶图谱技术。
淋巴瘤中逆转录病毒基因和细胞癌基因重排的研究
也将被研究。 (密歇根州)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SYAMAL K DATTA其他文献
SYAMAL K DATTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SYAMAL K DATTA', 18)}}的其他基金
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
- 批准号:
2882256 - 财政年份:1999
- 资助金额:
$ 29.36万 - 项目类别:
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
- 批准号:
6137339 - 财政年份:1999
- 资助金额:
$ 29.36万 - 项目类别:
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SLE 中 ANTICD40L 试验的免疫机制
- 批准号:
6341792 - 财政年份:1999
- 资助金额:
$ 29.36万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
2748628 - 财政年份:1993
- 资助金额:
$ 29.36万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
2457949 - 财政年份:1993
- 资助金额:
$ 29.36万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
6043194 - 财政年份:1993
- 资助金额:
$ 29.36万 - 项目类别:
MECHANISM OF AUTOIMMUNE RESPONSE IN HUMAN LUPUS
人类狼疮的自身免疫反应机制
- 批准号:
6374902 - 财政年份:1993
- 资助金额:
$ 29.36万 - 项目类别: